Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DM0RBQ5)

Drug Name	mRNA-1230 DM0RBQ5
Drug Type	Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Respiratory syncytial virus infection	DIS7FWHY	1C80	Phase 1	[1]
Coronavirus Disease 2019 (COVID-19)	DISM7GNX	1D6Y	Phase 1	[1]
Influenza	DIS3PNU3	1E30-1E32	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT05585632) Phase 1, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Multi-component Vaccines mRNA-1045 (Influenza and RSV) or mRNA-1230 (Influenza, RSV, and SARS-CoV-2) Compared With mRNA-1010 (Influenza), mRNA-1345 (RSV), and mRNA-1273.214 (SARS-CoV-2) Vaccines in Healthy Adults 50-75 Years of Age. U.S.National Institutes of Health.